INTRODUCTION
Lung cancer is a lethal adult cancer accounting for the most cancer deaths worldwide (1) . The most common form, Non-Small Cell Lung Carcinoma (NSCLC) represents >80% of all cases (2) . Over half of NSCLC patients have developed metastasis at the time of diagnosis and 5-year survival is ~14% (2) . Advanced NSCLC is poorly responsive to therapy and the mechanisms responsible for its resistance and aggressive behavior are not well defined.
Alterations in expression of microtubule proteins in cancer cells are emerging as important contributors to chemotherapy resistance (3, 4) . Microtubules are cytoskeletal proteins that comprise α-and β-tubulin heterodimers and are involved in many important cellular processes including maintenance of shape, intracellular transport and mitosis [reviewed in (4) ]. These critical roles make microtubules attractive drug targets for anticancer therapies. Indeed, chemotherapy agents including the microtubule stabilising (e.g. taxanes) and destabilising (e.g. vinca alkaloids) drugs exert their toxic effect by binding the β-tubulin subunit of microtubules to induce a potent mitotic block [reviewed in (4) ]. β-tubulin has seven isotypes that display tissue-specific expression.
For example, βI-tubulin is constitutively expressed in many tissues, whereas βII-tubulin and βIII-tubulin are expressed in neuronal tissues, and βIV-tubulin is restricted to hematopoietic tissues (3, 4) . Clinical studies show that high βIII-tubulin expression correlates with chemoresistance and poor survival in different tumor types, including breast, ovarian, gastric and NSCLC (5, 6) . Previously we demonstrated a functional role for βIII-tubulin in regulating chemosensitivity in NSCLC using RNA interference to silence βIII-tubulin expression in NSCLC cells (7) (8) (9) (10) . Knockdown of βIII-tubulin increased sensitivity via an increase in apoptosis to chemotherapeutic agents both in vitro and in vivo (7) (8) (9) (10) . However, despite evidence to link βIII-tubulin expression to chemotherapy drug sensitivity, its roles in the tumorigenic and metastatic potential of NSCLC are unknown. Recent clinical data has suggested that high βIII-tubulin expression is correlated to aggressive and metastatic tumors (11, 12) . In addition, we recently showed that silencing βIII-tubulin expression in the absence of chemotherapy delayed tumor growth in a mouse model of lung cancer (10) . However, how βIII-tubulin exerts its effect on tumor growth and its role in metastases of tumor cells remain unknown.
In this study, we show for the first time that stable suppression of βIII-tubulin in NSCLC cells alters the expression of key proteins involved in regulating tumorigenic and metastatic potential, alters cell morphology, increases anoikis sensitivity, and modulates PTEN/AKT signaling. Finally, we demonstrate that knockdown of βIII-tubulin in NSCLC cells decreases the incidence and growth of lung tumors in two different preclinical mouse models.
METHODS

Cell culture.
H460 and A549 NSCLC cells were obtained from ATTC and grown as described (8) (9) (10) .
H460 (pRS/βIII SH4 and pRS/βIII SH59 ) and A549 (pRS/βIII SH61 ) cell clones stably expressing shRNA targeting βIII-tubulin or control (non-functional) shRNA (pRS/Ctrl SH1 , pRS/Ctrl SH2, pRS/Ctrl SH27 ), and two H460 βIII-tubulin 'rescue' cell clones (pRS/βIII SH4 /R6
and pRS/βIII SH4 /R17) were developed and characterized as described (10) . All cells were routinely screened and found to be free of mycoplasma.
Two-Dimensional Differential Gel Electrophoresis (2D-DIGE).
2-D DIGE is a fluorescent based proteomics approach that uses charge and sizematched CyDye fluorophores that covalently attach to lysine residues for protein labeling prior to fractionation. A key strength of this assay is the ability to directly compare protein samples using a multiplex approach, while incorporating a standardized internal control (13, 14) . To identify differentially expressed proteins in NSCLC cells with stable suppression of βIII-tubulin, we performed 2-D DIGE on H460 βIII-tubulin shRNA (pRS/βIII SH4 and pRS/βIII SH59 ) or control shRNA (pRS/Ctrl SH1 and pRS/Ctrl SH2 ) cells ( Supplementary Fig 1) . 2D-DIGE was performed as we previously described with modifications (15) . Refer to Supplementary Method for detailed methodology. For analysis of the effects of βIII-tubulin knockdown, H460 pRS/βIII SH4 and pRS/βIII SH59 cells were grouped and compared to controls, H460 pRS/Ctrl SH1 and pRS/Ctrl SH2 cells. These comparisons were performed for both nuclear and cytoplasmic fractions at two pH ranges, pH 4.5-5.5 (narrow) or pH 4-7 (broad). Analysis of the fluorescent gel images was performed using the Batch Processor and Biological 
MALDI-TOF mass spectrometry.
Protein spots were excised from SYPRO Ruby stained gels and MALDI-TOF mass spectrometry performed as described (15) . Peptide masses were searched against SwissProt/TREMBL protein databases using the PeptIdent tool on ExPASY (http://tw.expasy.org/tools/peptident.html) for protein identification.
Western blotting.
Western blot analysis was performed using the following antibodies; βIII-tubulin (clone TUJ1, Chemicon), maspin (BD Biosciences), profilin 2 (AbCam), perioxiredoxin 4 (AbCam), total β-tubulin (AbCam), lamin B1 (AbCam), p-AKT (S473), pAKT (T308), total AKT, PTEN (Cell Signaling Technology) and GAPDH (Abcam) as described (10, 16) .
Immunofluorescence microscopy.
The actin cytoskeleton of NSCLC cells was visualized by phalloidin staining and imaged using a Zeiss immunofluorescence microscope (Zeiss).
Real time quantitative PCR (qPCR) analysis.
The expression of βIII-tubulin and maspin mRNA in NSCLC cells was examined by qPCR as described (10, 16) . All data were normalized to the housekeeping gene β 2 -microglobulin. 
Spheroid outgrowth assay
Tumor multicellular spheroids were generated in 96-well round bottom plates as described (17) . After formation, spheroids of uniform size were transferred to 6-well tissue culture plates and left to attach and grow for 24h. Images were captured on a Zeiss Axiovert 200M inverted microscope and cell outgrowth quantified using the AxioVision software package.
Anoikis assay.
To measure anchorage-independent cell death, βIII-tubulin shRNA expressing (pRS/βIII SH4 and pRS/βIII SH59 ), control (pRS/Ctrl SH1 and pRS/Ctrl SH2 ) or βIII-tubulin rescue (pRS/βIII SH4 /R17) cells were seeded onto poly-(2-hydroxyethyl methacrylate)-coated tissue culture plates. 48h post-seeding cells, cell death was measured as described (10, 18) .
In vivo mouse models. independence or in matrigel to mimic anchorage-dependence as described (10, 19) . Tumors were measured as described (10, 19) .
Experimental Metastasis
Micro-CT tumor analysis.
The presence of lung tumors in the mice was monitored by micro-computed tomography (CT) scanning. The micro-CT data were acquired using an Inveon system (Siemens) at 71.88 pixel size, 220 projections, 250ms integration time, 50keV photon energy and 450µA current. Image data were evaluated using the Inveon software package (Siemens). Tumor margins were identified by contrast thresh holding which allowed the tumor margins (soft tissue density) to be defined against the surrounding lung (air density).
STATISTICS
Data are expressed as the mean ± SE and analyzed using ANOVA or Student's t test followed by the nonparametric Dunnett test using the GraphPad Prism program. A P value of <0.05 was considered statistically significant. Table 1 ).
Western blot analysis confirmed the increase in maspin protein levels in pRS/βIII SH4 and SH59 cells when compared to controls ( Figure 1A-B) . Recently, studies have described the localization of maspin in the cytoplasm or the nucleus as being an important determinant in its tumor suppressor activity (21, 22) . To examine whether there was any difference in the cellular distribution of maspin in βIII-tubulin shRNA expressing cells, cytoplasmic and nuclear extracts were collected and maspin expression measured by western blot. Control shRNA expressing cells had higher maspin expression in their cytoplasm when compared to the nucleus ( Figure 1C ). βIII-tubulin shRNA expressing cells also had increased maspin expression in their cytoplasmic fraction compared to the nuclear fraction ( Figure 1C) . However, the expression of maspin was increased in both the cytoplasmic and nuclear fractions of the βIII-tubulin shRNA cells compared to control cells ( Figure 1C ). To determine whether this difference was reflected at the gene level, maspin gene expression was measured by qPCR. Maspin mRNA levels were increased in both βIII-tubulin shRNA expressing cell clones (pRS/βIII SH4 and SH59 ) compared to controls (pRS/Ctrl SH1 and SH2 ) ( Figure 1D ). The increase in maspin expression was also confirmed in another H460 NSCLC βIII-tubulin shRNA independent cell clone (pRS/βIII SH60 ) which also displayed potent knockdown of βIII-tubulin (Supplementary Figure 5) . Notably, this cell clone was not used in the 2D-DIGE experiments, thus adding further support to the correlation between βIII-tubulin knockdown and increased maspin expression.
To determine whether βIII-tubulin expression can directly influence maspin expression, βIII-tubulin was restored back into the βIII-tubulin shRNA expressing cells as described (10) Suppression of βIII-tubulin did not induce cell death in adherent conditions ( Figure 4C ).
In contrast, when kept in non-adherent conditions βIII-tubulin knockdown significantly increased anoikis sensitivity in both the pRS/βIII SH4 and pRS/βIII SH59 cell clones when compared to controls ( Figure 4C ). To confirm a direct correlation between βIII-tubulin expression and increased anoikis sensitivity, the same experiment was performed using the βIII-tubulin rescue (pRS/βIII SH4 /R17) cells. Re-expression of βIII-tubulin abolished the increased sensitivity to anoikis ( Figure 4D ).
βIII-tubulin modulates AKT activity and PTEN expression in NSCLC cells
To investigate the molecular mechanisms that mediate increased sensitivity to anoikis in βIII-tubulin knockdown cells, we examined the activation of the phosphatidylinositol 3-kinase (PI3K) downstream substrate AKT kinase. AKT is commonly dysregulated in tumor cells, and is important in promoting cell survival and resistance to anoikis (26) . To examine whether there was any difference in AKT activity in βIII-tubulin shRNA expressing cells, we measured AKT phosphorylation (p-AKT) at residues S473 and T308 (phosphorylation at both sites is required for full AKT activation) between control (pRS/Ctrl SH2 and SH27 ) and βIII-tubulin knockdown (pRS/βIII SH4 and SH61 ) H460 and A549 NSCLC cells. Both βIII-tubulin shRNA expressing NSCLC cell lines displayed a clear reduction in p-AKT expression at both S473 and T308 residues when compared to controls ( Figure 5A ). Remarkably, restoration of βIII-tubulin back into the H460 βIII-tubulin shRNA cells completely restored p-AKT levels at both phosphorylation sites ( Figure 5B) . Next, the expression of the upstream tumor suppressor PTEN which is a key regulator of AKT activation was measured. Loss of PTEN is observed in many types 
of cancer including NSCLC, which often leads to increased p-AKT (27) . Control cells had little PTEN expression ( Figure 5C ). Strikingly, NSCLC cells with stable βIII-tubulin knockdown displayed markedly increased PTEN expression ( Figure 5C ). Moreover, restoration of βIII-tubulin expression abolished the increase in PTEN expression, thus confirming that the low levels of βIII-tubulin were responsible for the differential expression of PTEN ( Figure 5C ). Finally, to determine whether the decrease in p-AKT activity in the βIII-tubulin knockdown cells, was in part mediated via increased PTEN expression, we transfected βIII-tubulin shRNA cells with PTEN siRNA ( Figure 6D ). Cells transfected with non-functional siRNA served as controls. Notably, the decrease in p-AKT expression levels was restored in the βIII-tubulin knockdown cells to the level of control cells ( Figure 5D ). These results suggest that high levels of βIII-tubulin in NSCLC cells influence p-AKT activity via PTEN.
To examine whether AKT activity is altered when NSCLC cells are exposed to nonadherent conditions, p-AKT levels were compared between the βIII-tubulin shRNA Collectively, the data provides strong evidence in two independent mouse models of NSCLC that βIII-tubulin levels influence tumor growth via a dependence of βIII-tubulin- favorable predictor for different tumors, including NSCLC (20) . However, for other tumor types such as pancreatic, gallbladder, colorectal and thyroid, high maspin expression has been associated with a poor prognosis (20) . These differences are thought to be attributed to its differential expression within the cell (i.e. cytoplasmic vs. nuclear) (20) .
Nevertheless, in NSCLC there is an increasing body of evidence to suggest that tumors with high maspin expression have a favorable prognosis (28) (29) (30) . These studies have been supported using in vitro and in vivo models of lung cancer. Beltran et al (31) demonstrated that restoration of maspin expression in NSCLC cells using artificial transcription factors combined with chromatin modifier compounds, reduced NSCLC metastatic behavior (31) . Maspin was also shown to be involved in regulating the survival of lung cancer cells to chemotherapy drugs (32) . Our studies showed that suppression of βIII-tubulin led to an increase in maspin expression, and that rescue of βIII-tubulin expression back into these cells was sufficient to bring maspin gene and protein expression back to control levels. This result confirms that the levels of βIII-tubulin are directly responsible for the differential expression of maspin in NSCLC cells.
The regulation of maspin in tumor cells is thought to involve a number of processes including control by transcription factors such as p53, ATF-2, PTEN and Snail (33) (34) (35) .
Interestingly, reports have demonstrated that the carboxy-terminal tail of βIII-tubulin is subject to post-translational modifications which can allow it to form protein-protein complexes with signaling proteins such as small GTPases and/or PKC in cancer cells (36, 37) . Furthermore, binding to these proteins initiated signaling cascades which promoted cellular survival under stress conditions. Therefore, it is possible that high (38) . Re-introduction of TM1 into these cells produced a striking alteration in the cytoskeleton with a flattened phenotype and prominent actin stress fibers. This correlated with a reduction in their tumorigenic potential by increased sensitivity to anoikis (38) . Notably, our proteomic analysis identified a significant increase in TM1 expression in the βIII-tubulin shRNA cells (supplementary table 1 ). In addition, studies have also reported that maspin can modulate changes in the expression of proteins associated with the cytoskeleton which correlate to increased cell adhesion and a reduced migratory phenotype (39) . We cannot exclude the possibility that maspin may be acting in concert with other proteins and it is possible that both TM1 and maspin may in part be involved in the re-organization of the cell cytoskeleton in NSCLC cells with suppressed βIII-tubulin.
Cancer cells must detach from an ECM matrix, survive under anchorage-independent conditions to travel in the blood or lymphatic system, and adhere and proliferate at new organ sites (40) . Therefore, tumor cells with metastatic potential have acquired altered mechanisms of cellular adhesion as well as resistance to anoikis (40, 41) . We demonstrated that suppression of βIII-tubulin prevented / delayed the ability of NSCLC cells to adhere and grow out from multicellular tumor spheroids. In addition, we showed that βIII-tubulin knockdown increased cell adhesion to fibronectin. These results support the notion that βIII-tubulin plays an important role in regulating cell-cell and cell-matrix interactions. We also demonstrated that suppression of βIII-tubulin sensitized NSCLC cells to anoikis. Importantly, anoikis was reversed by re-expression of βIII-tubulin indicating a direct correlation between βIII-tubulin levels and anoikis sensitivity. To gain an understanding into the mechanisms that link βIII-tubulin knockdown and increased anoikis, we examined the activation of the pro-survival signaling protein AKT in βIII-tubulin knockdown cells. There are numerous reports which highlight the importance of the AKT signaling pathway in tumor cells as a mechanism that promotes resistance to various forms of apoptosis (40) . Interestingly, we showed that suppression of βIII-tubulin correlated with a decrease in AKT phosphorylation at both phosphorylation sites (S473 and T308). Strikingly, AKT phosphorylation was fully restored following re-expression of βIII-tubulin. One of the key regulators of AKT activity is the tumor suppressor PTEN.
The principal catalytic function of this phosphatase is to dephosphorylate phosphatidylinositol-triphosphate which is a potent activator of AKT (42) . Loss of PTEN function leads to AKT signaling hyperactivation and is a common feature in a wide range of tumors (43) . In agreement with our finding that inhibition of βIII-tubulin expression correlates with decreased AKT phosphorylation, we showed that expression of PTEN is markedly increased in βIII-tubulin shRNA expressing cells. Furthermore, knockdown of PTEN using siRNA in the βIII-tubulin shRNA cells restored p-AKT activity back to controls. Finally, we showed that when kept in non-adherent conditions which is a surrogate marker for tumorigenicity and is an environment in which cells are susceptible to anoikis, AKT activation in βIII-tubulin shRNA cells became undetectable much earlier compared to control cells. The question that arises is how increased levels of βIII-tubulin influence the activity of an important pro-survival signaling pathway in NSCLC cells. Although more studies will be needed to fully answer this question, it should be noted, that silencing PTEN in the βIII-tubulin shRNA cells restored AKT phosphorylation when the cells were exposed to adherent-or non-adherent conditions. A recent study by Nam et al (32) showed that over-expression of maspin in NSCLC cells resulted in a significant reduction in AKT phosphorylation which correlated with increased expression of PTEN (32) . Therefore, it is tempting to speculate that the Rescue of βIII-tubulin expression (panels E and F) (H460 pRS/βIII R6 and R17) reduced the presence of actin stress fibers. Scale bar = 20μm, n = 3 independent experiments. 
